This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Jean Delbe: Innovator in Angiogenesis Inhibition
Introduction
Jean Delbe is a notable inventor based in Ville d'Avray, France. He has made significant contributions to the field of biotechnology, particularly in the area of angiogenesis inhibition. His work focuses on peptide fragments that have potential therapeutic applications in treating various proliferative disorders, including cancer.
Latest Patents
Delbe holds a patent for "Peptide fragments of the harp factor inhibiting angiogenesis." This invention concerns peptide fragments 13-39 and 65-97 of the HARP factor, which inhibit angiogenesis. Advantageously, these peptides can be associated with the peptide 111-136 of HARP. The invention also includes pharmaceutical compositions comprising these peptides or nucleic acids encoding them, along with their use for treating pathologies associated with angiogenesis.
Career Highlights
Throughout his career, Jean Delbe has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Université Paris Est Créteil Val de Marne. His research has contributed to advancements in understanding and manipulating biological processes related to angiogenesis.
Collaborations
Delbe has collaborated with notable colleagues, including Pierre Milhiet and Denis S. Barritault. These partnerships have further enriched his research and innovation in the field.
Conclusion
Jean Delbe's work in developing peptide fragments that inhibit angiogenesis represents a significant advancement in medical science. His contributions have the potential to lead to new treatments for serious health conditions, showcasing the importance of innovation in biotechnology.